Business Wire

GRAI-MATTER-LABS

1.10.2021 05:44:06 CEST | Business Wire | Press release

Share
GML and EZ-WHEEL Partner to Bring a Unique AI powered Wheel Drive to Autonomous Mobile Robots

GrAI Matter Labs (GML), a pioneer of brain-inspired computing solutions, announced today that it has entered into a partnership with ez-Wheel, a French company specializing in autonomous electric wheels, to develop an AI powered Wheel Drive for Autonomous Mobile Robots (AMRs) that will be available in 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210930006064/en/

The award winning ez-Wheel solution when combined with Life-Ready AI from GML will have a big impact to the logistics and supply chain industry by offering a safety certified mobile robotics platform capable of smart features like person tracking, obstacle avoidance and more. Thanks to optimal integration of motor, batteries, electronics and AI inside the hub, the "smart" wheel can be added quickly and easily to develop a safety compliant mobile robot, cutting development costs and providing flexible solutions for various deployments.

GML and ez-Wheel will introduce the AI powered Wheel Drive platform at the VISION / Motek-2021 tradeshows, which will take place in Stuttgart starting the 5th of October. GML will showcase a “Life-Ready AI” platform integrated in a mobile robot, and ez-Wheel will exhibit the “SWD® Starter Kit” featuring its safety certified AMR development platform.

“The partnership with ez-Wheel allows us to focus on robots for Industry 4.0 and meets an immediate need. It opens the door for a new era of collaborative mobile robotics by using GML's ‘Life-Ready AI’ GrAI VIP chip, a cutting-edge computing architecture that has never been seen before in such applications,” said Christian Verbrugge, GML Europe - Senior Director Business Development.

Antoine JUAN, CEO of ez-Wheel, is excited about the partnership, saying: “This amazing collaboration with GML empowers our new SWD® Safety Wheel Drive range with unprecedented features in the world of drives solutions. As an extension of our safety certified platform for mobile robots, the AI powered Wheel Drive will provide the robotics community with a powerful and versatile hardware toolkit, boosting the development of smart features like person-following, static infrastructure recognition, obstacle trajectory prediction and path optimization among many others. With a cost killing architecture and an extra low power consumption, the AI powered Wheel Drive will be a game changer.”

About GrAI Matter Labs

At GrAI Matter Labs we are in the business of Life-Ready AI. Artificial Intelligence as close to natural as it gets. AI that feels alive. We deliver brain-inspired chips that behave like humans. AI that makes machines act and react in real-time. AI that optimizes energy and maximizes efficiency, saving time, money, and vital natural resources. GML is led by a team of visionary and seasoned engineers and is backed by leading investors, including iBionext, 360 Capital Partners, 3T Finance, and Celeste Management.

For more information, please visit www.graimatterlabs.ai .

About ez-Wheel SAS

ez-Wheel SAS is an innovative technology company founded in 2009. The technology proposed by ez-Wheel is the fastest, simplest yet most advanced solution providing electric traction to mobile material dedicated to handling and transportation. In 2020, ez-Wheel introduced the world’s first Safety Wheel Drive with integrated safe motion control for mobile robotics. ez-Wheel’s products are used by hundreds of major industrial players in Europe.

For more information, please visit https://ez-wheel.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vena Completes Acterys Acquisition to Accelerate Orchestrated Planning for the Microsoft Ecosystem26.3.2026 14:00:00 CET | Press release

The combination connects AI-driven financial and operational planning, analytics and execution across Microsoft Excel and Power BI, removing decision latency for Microsoft-centric enterprises. Vena, the AI-powered Orchestrated Performance Management platform purpose-built to fully amplify the Microsoft technology ecosystem, today announced it has completed its acquisition of Acterys, the leading Microsoft Power BI–based operational planning and app development platform. The move strengthens Vena’s Orchestrated Planning solution and begins phased integration of the two platforms. Modern enterprises are struggling to keep up with the volatility and dynamism of the markets they serve. Market drivers and signals shift rapidly, and the ability to assess, plan and execute with confidence and speed is more important than ever. These forces, combined with overwhelming data density and disparity, have created a new constraint: decision latency—the time between signal and action. As that gap wid

Nearly Half of Global C-Suites Plan U.S. Expansion Within 12 Months, as Supply Chain and Capital Access Drive Growth26.3.2026 14:00:00 CET | Press release

• 45% of C-level executives plan to establish a U.S. legal entity within the next 12 months; a further 27% say they will consider entry within two to three years • 65% cite supply chain or manufacturing efficiency as the primary driver for U.S. expansion • 88% identify federal and state tax reporting as the most burdensome area of U.S. compliance Nearly half (45%) of global C-suite leaders plan to establish a legal entity in the United States within the next 12 months, highlighting continued demand for access to the U.S. market. This finding from the latest research by CSC—the leading provider of global business administration and compliance solutions—demonstrates the U.S. continues to attract investment from around the world, even as companies face an increasingly complex regulatory landscape. CSC surveyed 300 C-level executives at large organizations headquartered in Europe, the U.K., Asia Pacific, and South America to examine global sentiment toward U.S. market entry, including expa

Lone Star Funds Completes Acquisition of Alliance Ground International26.3.2026 13:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has completed the acquisition of Alliance Ground International (“AGI”), a leading North American airport services provider. “We are excited to partner with the AGI management team to drive the business forward,” said Donald Quintin, Chief Executive Officer of Lone Star. “The company has a superior service offering and a track record of success across its integrated operations. We see opportunities to continue to invest in the business and its people to continue to grow its capabilities and ensure it remains best-in-class in delivering for the aviation industry.” “Today marks an important next step for AGI as we move forward in partnership with Lone Star,” said Jared Azcuy, Chief Executive Officer of AGI. “Our commitment to safety, reliability, and operational service excellence remains unchanged. This partnership strengthens our ability to deliver for our airline partners and reinforces that the

Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging26.3.2026 13:30:00 CET | Press release

The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its primary endpoint and also demonstrated a statistically significant relationship between target engagement and clinical improvement in psoriasis and atopic dermatitis RLS-1496 is a first-in-class disease-modifying mechanism targeting pathological senescent cells that drive inflammaging and chronic degenerative diseases of aging A second study for RLS-1496 – a Phase 1b/2a study in actinic keratosis (precancerous skin lesions) – is underway in the United States, with completion expected later this year Rubedo CEO Frederick Beddingfield, III, MD, PhD, FAAD, to moderate panel on senescence and skin at the Dermatology Innovation Forum (DIF) during the American Academy of Dermatology (AAD) annual meeting on Thursday, March 26, at 1:05 pm MT in Denver Oral presentation of data accepted at the Society for Investigative Dermatology (SID) from May 13-16, 2026, in Chicago Rubedo L

GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe26.3.2026 13:30:00 CET | Press release

COMPASS is one of the largest public‑private partnerships under the European Union’s (EU) Innovative Health Initiative (IHI). The consortium aims to advance early detection and prediction of cardiotoxicity in cancer patients and cancer survivors. The initiative will leverage AI, advanced imaging, biomarkers, and integrated care pathways. GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of cardiovascular risks in cancer patients across Europe. COMPASS combines clinical excellence with novel healthcare technology, and with a total budget of €50.5 million and more than sixty partners, it is one of the largest public-private partnerships under the IHI. Cardiovascular diseases are rising sharply among cancer patients and survivors, driven both by the increasing prevalence of pre‑existing cardiovascular conditions at diagnosis and by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye